Jim Wassil
Known title: EVP, Chief Scientific Ofc, COOCIK: 0001813798
Associated companies
Transaction History
| PCVX | ▲ Buy | Option Exercise | 18,000 | $96K | 10/5/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 18,000 | $1.6M | 10/5/2026 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 2,250 | $12K | 10/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,155 | $122K | 10/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 95 | $5K | 10/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,334 | $79K | 9/9/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 5,459 | $330K | 9/8/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,381 | $84K | 9/4/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,432 | $88K | 9/2/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 303 | $19K | 9/1/2026 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 2,250 | $12K | 9/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,537 | $94K | 9/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 713 | $44K | 9/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 924 | $56K | 9/1/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,273 | $77K | 8/31/2026 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 2,250 | $12K | 8/3/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 861 | $46K | 8/3/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,389 | $75K | 8/3/2026 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 516 | $3K | 7/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,788 | $100K | 7/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 456 | $26K | 7/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 6 | $347 | 7/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 301 | $15K | 6/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,949 | $96K | 6/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,250 | $128K | 5/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,412 | $82K | 4/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 838 | $49K | 4/1/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,427 | $142K | 3/10/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,968 | $294K | 3/10/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 975 | $58K | 3/9/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,009 | $63K | 3/2/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 898 | $56K | 2/28/2026 | View on chart |
| PCVX | ▲ Buy | Grant | 5,102 | $315K | 2/27/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,900 | $117K | 2/27/2026 | View on chart |
| PCVX | ▲ Buy | Grant | 32,045 | $0 | 2/26/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,759 | $89K | 9/8/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,270 | $40K | 9/2/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,587 | $50K | 9/2/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,429 | $45K | 9/2/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 2,638 | $6K | 3/3/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 5,362 | $29K | 3/3/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,915 | $432K | 3/3/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,085 | $154K | 3/3/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 3,015 | $217K | 3/3/2025 | View on chart |
| PCVX | ▲ Buy | Grant | 5,649 | $412K | 2/28/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,869 | $209K | 2/28/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,270 | $93K | 2/28/2025 | View on chart |
| PCVX | ▲ Buy | Grant | 21,726 | $0 | 2/27/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $19K | 2/3/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,314 | $457K | 2/3/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,666 | $231K | 2/3/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 20 | $2K | 2/3/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $19K | 1/2/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,356 | $112K | 1/2/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,483 | $459K | 1/2/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,161 | $98K | 1/2/2025 | View on chart |
| PCVX | ▼ Sell | Gift | 74,000 | $0 | 12/31/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $19K | 12/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,772 | $531K | 12/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,101 | $102K | 12/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,127 | $106K | 12/2/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $19K | 11/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,955 | $527K | 11/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,174 | $233K | 11/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 631 | $68K | 11/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 240 | $26K | 11/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,585 | $8K | 10/28/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,464 | $73K | 10/28/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $19K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,312 | $262K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,349 | $383K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,339 | $269K | 10/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 10,000 | $24K | 9/16/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,784 | $205K | 9/16/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,994 | $928K | 9/16/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 222 | $26K | 9/16/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 10,000 | $24K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 258 | $28K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,072 | $228K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,102 | $344K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,263 | $253K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 367 | $41K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 389 | $44K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 344 | $40K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,195 | $139K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 10 | $1K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 5,545 | $611K | 9/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,977 | $235K | 8/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 23 | $2K | 8/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,226 | $93K | 7/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,663 | $128K | 7/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 111 | $9K | 7/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,634 | $117K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 906 | $66K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 460 | $34K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,753 | $107K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,062 | $66K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 185 | $12K | 5/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,551 | $19K | 4/17/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,323 | $155K | 4/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 677 | $46K | 4/1/2024 | View on chart |
| PCVX | ▲ Buy | Grant | 4,099 | $0 | 3/15/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,484 | $103K | 3/15/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,178 | $156K | 3/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,017 | $74K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,220 | $90K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 763 | $57K | 3/1/2024 | View on chart |
| PCVX | ▲ Buy | Grant | 20,000 | $0 | 2/29/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 27,917 | $68K | 2/15/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,000 | $7K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 527 | $38K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,056 | $77K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 467 | $35K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 950 | $72K | 2/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,000 | $7K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 289 | $18K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,039 | $66K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,562 | $100K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 110 | $7K | 1/2/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,000 | $7K | 12/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,067 | $55K | 12/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,933 | $101K | 12/1/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,000 | $7K | 11/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,878 | $136K | 11/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 122 | $6K | 11/1/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 5,000 | $12K | 10/12/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 850 | $44K | 10/2/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,000 | $7K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,542 | $77K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 608 | $31K | 10/2/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,000 | $7K | 9/22/2023 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,131 | $109K | 9/5/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 323 | $17K | 9/1/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,000 | $7K | 9/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,677 | $141K | 9/1/2023 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,189 | $49K | 3/2/2023 | View on chart |
| PCVX | ▲ Buy | Grant | 22,500 | $0 | 3/1/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 105,371 | $255K | 12/23/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 2,800 | $7K | 10/17/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 874 | $22K | 10/17/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,926 | $50K | 10/17/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 2,800 | $7K | 9/19/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,680 | $70K | 9/19/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 120 | $3K | 9/19/2022 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,162 | $57K | 9/2/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 2,800 | $7K | 8/17/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,800 | $70K | 8/17/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 2,800 | $7K | 7/1/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,800 | $62K | 7/1/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 2,800 | $7K | 4/18/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,800 | $67K | 4/18/2022 | View on chart |
| PCVX | ▲ Buy | Grant | 25,000 | $0 | 3/2/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 10,000 | $24K | 2/24/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 10,000 | $220K | 2/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Vaxcyte VAX-31 clears Phase III OPUS-1 trial endpoints
Vaxcyte announced that its VAX-31 vaccine met all primary endpoints in the pivotal Phase III OPUS-1 trial. This positive data point positions the company for additional readouts expected in the first half of 2027. The stock is currently trading near its 52-week high, reflecting strong market interest in the clinical progress.
Vaxcyte VAX-31 clears Phase III OPUS-1 trial endpoints. Vaxcyte announced that its VAX-31 vaccine met all primary endpoints in the pivotal Phase III OPUS-1 trial. This positive data point positions the company for additional readouts expected in the first half of 2027. The stock is currently trading near its 52-week high, reflecting strong market interest in the clinical progress.